Aerovate Therapeutics (AVTE) Institutional Ownership $8.23 +0.85 (+11.52%) As of 08/22/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aerovate Therapeutics (NASDAQ:AVTE)Number ofInstitutional Buyers(last 12 months)38TotalInstitutional Inflows(last 12 months)$752.30MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$51.99M Get AVTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTE Institutional Buying and Selling by Quarter Aerovate Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025 Goldman Sachs Group Inc.352,669$885K0.0%+12.2%1.217% 5/29/2025 Rhumbline Advisers22,750$57K0.0%+67.3%0.078% 5/21/2025 Acadian Asset Management LLC15,980$40K0.0%-81.4%0.055% 5/19/2025 Jane Street Group LLC11,009$28K0.0%N/A0.038% 5/16/2025 Goldman Sachs Group Inc.352,669$885K0.0%+12.2%1.217% 5/16/2025 AQR Capital Management LLC21,633$54K0.0%+14.7%0.075% 5/16/2025 Allostery Investments LP1,421,568$3.57M5.1%+67.1%4.904% 5/16/2025 ADAR1 Capital Management LLC1,461,234$3.67M0.7%+57.5%5.041% 5/13/2025 Kovitz Investment Group Partners LLC26,514$67K0.0%N/A0.091% 5/13/2025 Russell Investments Group Ltd.32,395$81K0.0%+113.3%0.112% Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Nuveen LLC40,047$101K0.0%N/A0.138% 5/12/2025 Invesco Ltd.74,440$187K0.0%N/A0.257% 5/9/2025 PNC Financial Services Group Inc.13,962$35K0.0%+8,210.7%0.048% 5/8/2025 XTX Topco Ltd18,739$47K0.0%-21.1%0.065% 4/22/2025 Deltec Asset Management LLC361,804$908K0.2%+86.4%1.248% 4/8/2025 Rhumbline Advisers22,750$57K0.0%+67.3%0.078% 2/27/2025Jefferies Financial Group Inc.600,000$1.59M0.0%N/A2.078% 2/18/2025 GTS Securities LLC10,082$27K0.0%N/A0.035% 2/17/2025 Squarepoint Ops LLC19,564$52K0.0%N/A0.068% 2/17/2025 Two Sigma Advisers LP153,600$407K0.0%+38.5%0.532% 2/17/2025 Two Sigma Investments LP226,121$599K0.0%-27.8%0.783% 2/17/2025 Millennium Management LLC65,698$174K0.0%-66.6%0.228% 2/17/2025Jefferies Financial Group Inc.600,000$1.59M0.0%N/A2.078% 2/17/2025 Bridgeway Capital Management LLC60,000$159K0.0%N/A0.208% 2/17/2025 Braidwell LP1,440,499$3.82M0.1%N/A4.989% 2/17/2025 Blackstone Inc.499,566$1.32M0.0%N/A1.730% 2/17/2025 Bank of America Corp DE231,085$612K0.0%-11.5%0.800% 2/17/2025 BNP Paribas Financial Markets54,688$145K0.0%N/A0.189% 2/17/2025 Allostery Investments LP850,684$2.25M2.3%N/A2.946% 2/14/2025 Nantahala Capital Management LLC482,928$1.28M0.1%N/A1.672% 2/14/2025 Northern Trust Corp106,692$283K0.0%+6.3%0.369% 2/14/2025 Vazirani Asset Management LLC75,000$199K0.6%N/A0.260% 2/14/2025 Harvest Investment Services LLC23,919$63K0.0%N/A0.083% 2/13/2025 Affinity Asset Advisors LLC800,000$2.12M0.3%+33.3%2.770% 2/13/2025 XTX Topco Ltd23,745$63K0.0%N/A0.082% 2/13/2025 Scotia Capital Inc.37,210$99K0.0%N/A0.129% 2/13/2025 Renaissance Technologies LLC44,600$118K0.0%+149.2%0.154% 2/13/2025 ADAR1 Capital Management LLC928,016$2.46M0.5%+720.7%3.213% 2/13/2025 Bank of Montreal Can59,097$157K0.0%+86.8%0.205% 2/13/2025 Russell Investments Group Ltd.15,184$40K0.0%+110.7%0.053% Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow2/12/2025 JPMorgan Chase & Co.67,165$178K0.0%+1,021.1%0.233% 2/10/2025 Corient Private Wealth LLC36,897$98K0.0%N/A0.128% 2/3/2025 Ieq Capital LLC14,377$38K0.0%N/A0.050% 1/27/2025 Deltec Asset Management LLC194,124$514K0.1%N/A0.672% 1/13/2025 FNY Investment Advisers LLC75,000$198K0.1%N/A0.260% 11/19/2024 Barclays PLC18,972$39K0.0%+310.8%0.066% 11/16/2024 Geode Capital Management LLC291,887$610K0.0%-8.0%1.011% 11/15/2024 Barclays PLC18,972$39K0.0%+310.8%0.066% 11/15/2024 Jane Street Group LLC17,805$37K0.0%-86.0%0.062% 11/15/2024 State Street Corp367,468$768K0.0%+7.7%1.272% 11/14/2024 Verition Fund Management LLC99,815$209K0.0%-59.9%0.346% 11/13/2024 FMR LLC82,919$173K0.0%+54,095.4%0.287% 11/12/2024 Charles Schwab Investment Management Inc.29,351$61K0.0%-43.7%0.102% 11/5/2024 GSA Capital Partners LLP413,795$865K0.1%+226.8%1.433% 9/16/2024 Cubist Systematic Strategies LLC31,894$53K0.0%N/A0.111% 8/15/2024 Deerfield Management Company L.P. Series C1,411,608$2.34M0.0%N/A4.898% 8/15/2024 Affinity Asset Advisors LLC200,000$332K0.0%N/A0.694% 8/14/2024 Cubist Systematic Strategies LLC31,894$53K0.0%N/A0.111% 8/12/2024 XTX Topco Ltd21,143$35K0.0%N/A0.073% 8/9/2024 Atlas Venture Life Science Advisors LLC1,799,232$2.99M0.3%-11.8%6.243% 8/9/2024 Warberg Asset Management LLC67,449$111K0.0%N/A0.234% 8/6/2024 Quest Partners LLC32,856$55K0.0%+610.2%0.114% 7/26/2024 Bank of New York Mellon Corp46,988$78K0.0%+69.9%0.163% 7/19/2024 Values First Advisors Inc.15,381$26K0.0%N/A0.053% 7/12/2024 SG Americas Securities LLC179,493$298K0.0%N/A0.623% 5/17/2024 Ikarian Capital LLC367,965$10.88M1.2%N/A1.277% 5/16/2024 California State Teachers Retirement System1,124$33K0.0%-38.9%0.004% 5/14/2024 EntryPoint Capital LLC3,126$92K0.1%-49.0%0.011% 5/10/2024 Vanguard Group Inc.672,275$19.88M0.0%+7.2%2.410% 2/20/2024 Eventide Asset Management LLC12,178$276K0.0%N/A0.044% 2/15/2024 Octagon Capital Advisors LP403,685$9.14M1.5%-18.8%1.459% 2/15/2024 Parkwood LLC15,786$357K0.0%-23.6%0.057% 2/15/2024 Great Point Partners LLC1,037,690$23.48M4.0%-4.9%3.750% 2/14/2024 Vestal Point Capital LP400,000$9.05M1.0%N/A1.446% 11/15/2023 Alps Advisors Inc.20,395$277K0.0%+11.3%0.074% 11/14/2023 Fred Alger Management LLC24,747$336K0.0%-57.2%0.090% 11/13/2023 Silverarc Capital Management LLC100,000$1.36M0.4%N/A0.362% 11/13/2023 FMR LLC529,544$7.19M0.0%-27.2%1.915% 11/8/2023 Swiss National Bank21,201$288K0.0%+30.9%0.077% 9/21/2023 Barclays PLC3,406$58K0.0%-27.8%0.012% 8/15/2023 HighVista Strategies LLC41,803$717K0.3%+164.0%0.151% 8/14/2023 Great Point Partners LLC932,158$15.99M3.1%+23.4%3.377% 8/14/2023 TCG Crossover Management LLC2,201,274$37.75M6.2%+103.6%7.976% 8/14/2023 Driehaus Capital Management LLC1,194,091$20.48M0.3%N/A4.326% 7/31/2023 Strs Ohio2,300$39K0.0%N/A0.008% 6/1/2023 Golden State Equity Partners10,530$212K0.1%N/A0.042% 5/16/2023 Great Point Partners LLC755,620$15.24M3.0%+99.6%3.046% 5/16/2023 Atlas Venture Life Science Advisors LLC2,039,249$41.13M5.6%+1.1%8.219% 5/16/2023 Baker BROS. Advisors LP1,963,479$39.60M0.2%-0.7%7.914% 5/15/2023Ghost Tree Capital LLC200,000$4.03M1.2%+48.1%0.806% Washington Thinks They Own Your Bank Account (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >>5/12/2023 Nan Fung Group Holdings Ltd47,936$967K0.7%-5.3%0.193% 5/11/2023 Skandinaviska Enskilda Banken AB publ50,866$1.03M0.0%-4.6%0.205% 3/23/2023 MetLife Investment Management LLC5,228$153K0.0%N/A0.021% 2/15/2023 Eversept Partners LP91,252$2.67M0.2%N/A0.374% 2/15/2023 Atlas Venture Life Science Advisors LLC2,017,521$59.11M7.1%-13.3%8.265% 2/15/2023 Nantahala Capital Management LLC15,700$460K0.0%N/A0.064% 2/14/2023 VR Adviser LLC747,869$21.91M3.5%-10.3%3.064% 2/14/2023 Parkwood LLC20,560$602K0.1%-3.7%0.084% 2/10/2023Cheyne Capital Management UK LLP18,927$555K1.0%N/A0.078% 2/8/2023 Skandinaviska Enskilda Banken AB publ53,340$1.56M0.0%-5.5%0.219% (Data available from 1/1/2016 forward) AVTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTE shares? During the previous two years, 65 institutional investors and hedge funds held shares of Aerovate Therapeutics. The most heavily invested institutionals were Great Point Partners LLC ($23.48M), Vanguard Group Inc. ($19.88M), Ikarian Capital LLC ($10.88M), Octagon Capital Advisors LP ($9.14M), Vestal Point Capital LP ($9.05M), Braidwell LP ($3.82M), and ADAR1 Capital Management LLC ($3.67M).Learn more on Aerovate Therapeutics' institutional investors. Which institutional investors have been buying Aerovate Therapeutics' stock? Of the 51 institutional investors that purchased Aerovate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($1.44M), Allostery Investments LP ($1.42M), Deerfield Management Company L.P. Series C ($1.41M), ADAR1 Capital Management LLC ($1.35M), Jefferies Financial Group Inc. ($1.20M), Blackstone Inc. ($499.57K), and Nantahala Capital Management LLC ($482.93K). How much institutional buying is happening at Aerovate Therapeutics? Institutional investors have bought a total of 8,294,817 shares in the last 24 months. This purchase volume represents approximately $752.30M in transactions. Which of Aerovate Therapeutics' major shareholders have been selling company stock? Of the 9 institutional investors that sold Aerovate Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Verition Fund Management LLC ($149.14K), Millennium Management LLC ($130.95K), Jane Street Group LLC ($109.36K), Two Sigma Investments LP ($86.99K), Acadian Asset Management LLC ($69.81K), Bank of America Corp DE ($29.95K), and Geode Capital Management LLC ($25.29K). How much institutional selling is happening at Aerovate Therapeutics? Institutional investors have sold a total of 629,223 shares in the last 24 months. This volume of shares sold represents approximately $51.99M in transactions. Related Companies Immunome Institutional Ownership Pharming Group Institutional Ownership uniQure Institutional Ownership Akebia Therapeutics Institutional Ownership Anavex Life Sciences Institutional Ownership Sana Biotechnology Institutional Ownership atai Life Sciences Institutional Ownership ArriVent BioPharma Institutional Ownership Oculis Institutional Ownership BGM Group Institutional Ownership This page (NASDAQ:AVTE) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.